Skip To Main Content
Orlin Besarboliev on Muck Rack

Orlin Besarboliev

As seen in: MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Orlin

Contact Orlin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

X-ray Single-Crystal Analysis, Pharmaco-Toxicological Profile and Enoyl-ACP Reductase-Inhibiting Activity of Leading Sulfonyl Hydrazone Derivatives

|
By Yoanna Teneva, Rumyana Simeonova, Orlin Besarboliev, Hristina Sbirkova-Dimitrova
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

X-ray Single-Crystal Analysis, Pharmaco-Toxicological Profile and Enoyl-ACP Reductase Inhibiting Activity of Leading Sulfonyl Hydrazone Derivatives with Potent Antimycobacterial Activity

|
By Yoanna Teneva, Rumyana Simeonova, Hristina Sbirkova-Dimitrova, Orlin Besarboliev
| preprints.org
Preprint Article Version 1 This version is not peer-reviewed Version 1 : Received: 22 May 2024 / Approved: 22 May 2024 / Online: 23 May 2024 (10:01:34 CEST) Teneva, Y.; Simeonova, R.; Besarboliev, O.; Sbirkova-Dimitrova, H.; Angelova, V. T. X-ray Single-Crystal Analysis, Pharmaco-Toxicological Profile and Enoyl-ACP Reductase Inhibiting Activity of Leading Sulfonyl Hydrazone Derivatives with Potent Antimycobacterial Activity. Preprints 2024, 2024051470.
Open in Who Shared Issue with article?
See all 2 articles